Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Symmetry Medical Gets 510K Clearance For FLASH PAK Evolution Valve - Quick Facts

RELATED NEWS
Trade SMA now with 

Symmetry Medical Inc. (SMA: Quote) said it received United States Food and Drug Administration or FDA 510K clearance for its FLASH PAK Evolution valve. The Evolution valve is the next generation valve for Symmetry's immediate use (flash) sterilization product, FLASH PAK, and is distributed exclusively through Symmetry Surgical. The company added that the patent pending stainless steel construction of the new valve is designed for ease of use and simplicity of care.

Chris Huntington, chief operating officer of Symmetry Surgical, said, "Making care and maintenance of our products easy is a key mission of Symmetry Surgical. The Evolution valve brings a new level of innovation to our market leading FLASH PAK; a product that clinicians have grown to depend on for over 20 years."

Click here to receive FREE breaking news email alerts for Symmetry Medical Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The U.K. economy grew at a slower pace in the third quarter in the face of rising uncertainty stemming from global economic conditions, preliminary estimates from the Office for National Statistics Office showed Friday. Gross domestic product climbed 0.7 percent from the second quarter, when it grew 0.9 percent. German consumer climate is set to improve slightly in November, ending the downward trend, as income expectations among households strengthened on the back of the strong labor market situation, survey data revealed Friday.The forward-looking consumer confidence index rose slightly to 8.5 in November from 8.4 in October. Software giant Microsoft Corp. said Thursday after the markets closed that its first quarter profit fell 13% from last year, hurt mainly by integration and restructuring costs even as revenue surged 25% thanks to strong sales of its gadgets and cloud-based products. However, the company's quarterly earnings per share came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.